Differential Expression of Syndecan-1/CD138 in Triple Negative Breast Carcinoma and Hormone Receptor Positive Breast Carcinoma

被引:0
|
作者
Patel, S.
Cohen, C.
McLendon, L. A.
Husman, A.
Schmechel, S.
Busch, R.
Stevens, K.
Adams, A.
Oprea, G. M.
机构
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Minnesota, Minneapolis, MN USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
231
引用
收藏
页码:58A / 58A
页数:1
相关论文
共 50 条
  • [1] Differential Expression of Syndecan-1/CD138 in Triple Negative Breast Carcinoma and Hormone Receptor Positive Breast Carcinoma
    Patel, S.
    Cohen, C.
    McLendon, L. A.
    Husman, A.
    Schmechel, S.
    Busch, R.
    Stevens, K.
    Adams, A.
    Oprea, G. M.
    [J]. MODERN PATHOLOGY, 2012, 25 : 58A - 58A
  • [2] Syndecan-1/CD138 Expression in Triple Negative Breast Carcinoma
    Husman, A. L.
    Adams, A. L.
    Cohen, C.
    Page, A. J.
    Sullivan, H. C.
    Oprea, G. M.
    [J]. MODERN PATHOLOGY, 2011, 24 : 44A - 44A
  • [3] Syndecan-1/CD138 Expression in Triple Negative Breast Carcinoma
    Husman, A. L.
    Adams, A. L.
    Cohen, C.
    Page, A. J.
    Sullivan, H. C.
    Oprea, G. M.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 44A - 44A
  • [4] Syndecan-1 (CD138) expression is related to an aggressive phenotype and to poorer prognosis to breast carcinoma
    Barbareschi, M
    Aldovini, D
    Maisonneuve, P
    Cangi, MG
    Pecciarini, L
    Mauri, FA
    Caffo, O
    Galligioni, E
    Dalla Palma, P
    Doglioni, C
    [J]. LABORATORY INVESTIGATION, 2001, 81 (01) : 21A - 21A
  • [5] Syndecan-1 (CD138) expression is related to an aggressive phenotype and to poorer prognosis in breast carcinoma.
    Barbareschi, M
    Aldovini, D
    Maisonneuve, P
    Cangi, MG
    Pecciarini, L
    Mauri, FA
    Caffo, O
    Galligioni, E
    Dalla Palma, P
    Doglioni, C
    [J]. MODERN PATHOLOGY, 2001, 14 (01) : 21A - 21A
  • [6] Down expression of syndecan-1 (CD138) in nasopharyngeal carcinoma (NPC)
    Chen, CL
    [J]. MODERN PATHOLOGY, 2005, 18 : 211A - 212A
  • [7] Down expression of syndecan-1 (CD138) in nasopharyngeal carcinoma (NPC)
    Chen, CL
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 211A - 212A
  • [8] Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer
    Ismail, Yahia
    Zakaria, Al-Shimaa
    Allam, Rasha
    Goette, Martin
    Ibrahim, Sherif Abdelaziz
    Hassan, Hebatallah
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [9] Differential expression of syndecan-1 (CD138) in myxoid soft TissueTumors
    Liu, J.
    Haupt, H. M.
    Brooks, J. J.
    [J]. MODERN PATHOLOGY, 2007, 20 : 18A - 18A
  • [10] Syndecan-1 (CD138) expression in adenocarcinomas of the endometrium
    Willis, C
    Olson, S
    Washington, K
    Shappell, H
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 214A - 214A